AAPG biotech catalysts & pipeline

APG-3288 — Initial data

2026

BTK Protein Degrader APG-3288 global Phase I PK, safety, tolerability, efficacy data, including U.S. and China; Advancement of EED Inhibitor APG-5918 in oncology and anemia in the U.S. and China.